# Oregon Clinical and Translational Research Institute KL2 Program

> **NIH NIH KL2** · OREGON HEALTH & SCIENCE UNIVERSITY · 2020 · $858,960

## Abstract

The goal of the OCTRI KL2 program is to train a corps of clinical and translational scientists in the skills and
competencies of clinical and translational research who can use cutting edge technologies to translate
discoveries made in the laboratory to the patient and the community. Through this program, we will select
outstanding early faculty who are committed to developing a research career; each of the scholars will
participate in a mentored research experience for a minimum of 0.75 FTE. Scholars will develop a career
development plan with the aid of a mentor team – which will include a designated primary mentor – to assist
with career development, networking, manuscript writing, and grant development.
All scholars will participate in activities that are specific to and that will enhance their research and career
development needs: development of research competencies in clinical and translational research, professional
activities, and experiential learning. Many scholars will enroll in the curriculum of the Master of Clinical
Research (MCR) program; all scholars must participate in training in qualitative methods, scientific
communication, and research leadership. Professional development includes opportunities through the OCTRI
Scholar program for peer networking, Design Studio, and access to research consultation. Community
engagement will be emphasized in research development, with all scholars gaining experience with
stakeholders. Scholars will also gain experience with grant writing and grant review. They will have
opportunities to participate in specific experiences, such as working with centers for health policy and
evidence-based practice; allowing scholars to learn how to write a systematic review or to develop an
evidence-based guideline.
The goal of this program is to produce an independent, transdisciplinary clinical and translational researcher.
The expectation is that scholars will move to an independent K award at the end of the KL2 funding period;
exceptional scholars may move directly to an RPG.

## Key facts

- **NIH application ID:** 9970561
- **Project number:** 5KL2TR002370-04
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** David B Jacoby
- **Activity code:** KL2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $858,960
- **Award type:** 5
- **Project period:** 2017-09-02 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9970561

## Citation

> US National Institutes of Health, RePORTER application 9970561, Oregon Clinical and Translational Research Institute KL2 Program (5KL2TR002370-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9970561. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*